| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 25,430 | 32,249 | 28,676 | | Cost of Revenue | 6,306 | 6,000 | 5,416 | | | Gross Profit | 19,124 | 26,250 | 23,259 | | | Operating Expenses | | Research Development | 6,413 | 5,983 | 3,845 | | Selling General and Administrative | 14,248 | 21,784 | 16,350 | | Non Recurring | 7,750 |
-
|
-
| | Others | 6,248 |
-
|
-
| | | | Total Operating Expenses | 34,659 |
-
|
-
| | | | Operating Income or Loss | (15,535) | (1,518) | 3,064 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,450 | 6,859 | 3,981 | | Earnings Before Interest And Taxes | (11,085) | 5,342 | 7,046 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (11,085) | 5,342 | 7,046 | | Income Tax Expense | 40 | 433 | 83 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,258) | 4,908 | 6,963 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (11,258) | 4,908 | 6,963 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,258) | $4,908 | $6,963 |
|
0.12% Nasdaq 
0.11 (3.82%) 
Income Statement
